| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SHIRE PLC | 409,858 | 26,595,290 | 4.22% | ||
| 2 | LILLY ELI & CO | 255,000 | 20,466,300 | 3.25% | ||
| 3 | ALEXION PHARMACEUTIC | 161,702 | 19,814,963 | 3.15% | ||
| 4 | CELGENE CORP | 186,000 | 19,442,580 | 3.09% | ||
| 5 | Pfizer Inc | 555,355 | 18,809,874 | 2.99% | ||
| 6 | ALLERGAN PLC | 79,500 | 18,309,645 | 2.91% | ||
| 7 | UNITEDHEALTH GROUP INC | 130,000 | 18,200,000 | 2.89% | ||
| 8 | BIOGEN INC | 57,000 | 17,842,710 | 2.83% | ||
| 9 | INCYTE | 185,000 | 17,443,650 | 2.77% | ||
| 10 | Gilead Sciences Inc | 207,304 | 16,401,892 | 2.61% | ||
| 11 | Medtronic Plc | 169,078 | 14,608,339 | 2.32% | ||
| 12 | CVS HEALTH CORP | 160,000 | 14,238,400 | 2.26% | ||
| 13 | BIOMARIN | 140,000 | 12,952,800 | 2.06% | ||
| 14 | BRISTOL MYERS SQUIBB CO | 237,000 | 12,779,040 | 2.03% | ||
| 15 | MERCK & CO INC | 200,000 | 12,482,000 | 1.98% | ||
| 16 | TEVA PHARMACEUTICAL INDS LTD | 270,000 | 12,422,700 | 1.97% | ||
| 17 | REGENERON PHARMACEUTICALS | 29,500 | 11,859,590 | 1.88% | ||
| 18 | ZIMMER BIOMET HLDGS INC | 85,000 | 11,051,700 | 1.76% | ||
| 19 | CIGNA CORPORATION | 84,000 | 10,946,880 | 1.74% | ||
| 20 | ABIOMED INC | 85,000 | 10,929,300 | 1.74% | ||
| 21 | ARIAD PHARMACEUTICALS INC | 675,000 | 9,240,750 | 1.47% | ||
| 22 | AMGEN INC | 55,000 | 9,174,550 | 1.46% | ||
| 23 | ALNYLAM PHARMACEUTICALS INC | 130,000 | 8,811,400 | 1.40% | ||
| 24 | Anthem Inc | 67,434 | 8,450,155 | 1.34% | ||
| 25 | HCA HOLDINGS INC | 110,000 | 8,319,300 | 1.32% | ||
| 26 | ALKERMES PLC SHS | 175,599 | 8,258,421 | 1.31% | ||
| 27 | EXPRESS SCRIPTS HLDG CO | 111,000 | 7,828,830 | 1.24% | ||
| 28 | EXELIXIS INC | 600,000 | 7,674,000 | 1.22% | ||
| 29 | JAZZ PHARMACEUTICALS PLC SHS USD | 60,000 | 7,288,800 | 1.16% | ||
| 30 | ENDO INTL | 360,200 | 7,258,030 | 1.15% | ||
| 31 | HOLOGIC INC | 180,000 | 6,989,400 | 1.11% | ||
| 32 | VERTEX PHARMACEUT | 80,013 | 6,977,934 | 1.11% | ||
| 33 | ABBVIE INC | 110,000 | 6,937,700 | 1.10% | ||
| 34 | NEKTAR THERAPEUTICS COM | 390,000 | 6,700,200 | 1.06% | ||
| 35 | SUPERNUS PHARMACEUTICALS INC COM | 270,000 | 6,677,100 | 1.06% | ||
| 36 | EDWARDS LIFESCIENCES CORP | 55,000 | 6,630,800 | 1.05% | ||
| 37 | HORIZON PHARMA PLC | 365,000 | 6,617,450 | 1.05% | ||
| 38 | ZELTIQ AESTHETICS INCORPORATED | 160,000 | 6,275,200 | 1.00% | ||
| 39 | DEXCOM | 65,000 | 5,697,900 | 0.90% | ||
| 40 | ENDOLOGIX INC | 435,000 | 5,568,000 | 0.88% | ||
| 41 | XENCOR INC COM | 225,000 | 5,510,250 | 0.88% | ||
| 42 | CENTENE CORP DEL | 80,000 | 5,356,800 | 0.85% | ||
| 43 | Lion Biotechnologies | 650,000 | 5,349,500 | 0.85% | ||
| 44 | WALGREENS BOOTS ALLIANCE INC | 65,000 | 5,240,300 | 0.83% | ||
| 45 | NEVRO CORP | 49,300 | 5,146,427 | 0.82% | ||
| 46 | RIGEL PHARMACEUTICAL INC | 1,400,000 | 5,138,000 | 0.82% | ||
| 47 | KITE PHARMA INCORPORATED | 90,000 | 5,027,400 | 0.80% | ||
| 48 | AETNA INC NEW | 42,000 | 4,848,900 | 0.77% | ||
| 49 | OMNICELL COM COM | 118,537 | 4,539,967 | 0.72% | ||
| 50 | HUMANA | 25,000 | 4,422,250 | 0.70% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001415889-16-007347, filed 2016.11.08).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
